All Journals > Infection Control and Hospital Epidemiology > March 2006 > Surveillance of Antimicrobial Resistance

Article Tools

Search for Related Articles

Highlighted Article

NHSN Annual Update:
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections

Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007

Antimicrobial-resistant pathogens that cause healthcare-associated infections (HAIs) pose an ongoing and increasing challenge to hospitals, both in the clinical treatment of patients and in the prevention of the cross-transmission of these problematic pathogens.  Describing the magnitude of the problem with respect to these antimicrobial-resistant pathogens is challenging, because the levels of antimicrobial resistance vary for different types of healthcare facilities and for different geographic areas, and some resistance phenotypes are difficult for laboratories to detect. However, the findings from such attempts may help the infection control and public health communities target problems and utilize resources more efficiently.

In the News

Featured in The Times
"Ireland 'losing war' on superbug" February 15, 2009
Challenges of Implementing National Guidelines for the Control and Prevention of Methicillin‐Resistant Staphylococcus aureus Colonization or Infection in Acute Care Hospitals in the Republic of Ireland
Fidelma Fitzpatrick, MD; Fiona Roche, PhD; Robert Cunney, MB; Hilary Humphreys, MD; Strategy for the Control of Antimicrobial Resistance in Ireland Infection Control Subcommittee
The research, published in Infection Control and Hospital Epidemiology, found one third of hospitals did not have a written policy on antibiotic use, and only 35% had an antibiotic stewardship programme.

March 2006

Volume 27, Number 3
Infect Control Hosp Epidemiol 2006;27:299–301
0899-823X/2006/2703-0013$15.00
DOI: 10.1086/501542
Concise Communication

Use of Local Community Hospital Data for Surveillance of Antimicrobial Resistance

Susan M. Farner, PhD

Dr. Farner is from the University of Illinois Urbana‐Champaign, Champaign, Illinois.

We sought to determine whether antimicrobial susceptibility data from a nonteaching community hospital could be used to detect statistically significant local increases in resistance among Streptococcus pneumoniae over a 5‐year period. Minimum inhibitory concentrations (MICs) of penicillin and ceftriaxone from 1997‐1998 were compared with those from 2000‐2001. MICs of penicillin and ceftriaxone for organisms collected in a nonteaching community hospital in central Illinois were used for analysis. The hospital has 224 beds and a catchment area of approximately 40 miles. There were significant increases in MICs of penicillin and ceftriaxone between 1997‐1998 and 2000‐2001. The MIC of penicillin increased from 0.042 to 0.121 μg/mL ( ; 95% confidence interval, −1.713 to −0.388), and the MIC of ceftriaxone increased from 0.028 to 0.071 μg/mL ( ; 95% confidence interval, −1.353 to −0.188). There were no significant changes in the percentage of S. pneumoniae isolates that were resistant, intermediate, or susceptible to penicillin and ceftriaxone. MIC data from a community hospital can be used to detect local increases in the rate of resistance before antibiogram data show significant changes. This information is important for demonstrating to physicians the need to review local antibiotic use in the attempt to slow the development of resistant organisms in the community.

Received September 14, 2005; accepted January 26, 2006; electronically published February 24, 2006.

Address reprint requests to Susan M. Farner, PhD, 127 Huff Hall, 1206 South Fourth Street, Champaign, IL 61820 ().
Close Popup